Temporal lobe epilepsy (TLE) is the most prevalent and often devastating form of epilepsy. The molecular 1 5 mechanism underlying the development of TLE remains largely unknown, which hinders the discovery of 1 6 effective anti-epileptogenic drugs. In this study, we built a systems-level analytic framework which 1 7
Introduction 1 5 0 lists using the following equation (Eq. 1).
The gene lists with the normalized rank (R norm ) and average log 2 FC was then served as gene 1 4 to these GO terms were extracted using the biomaRt package [36] . These candidate regulators along with 2 1 5 the gene expression matrix were subjected to the ARACNe-AP software [37] for reverse engineering a 2 1 6 gene regulatory network. ARACNe was run with 100 bootstrap iterations with parameters set to 0 DPI 2 1 7
(data processing inequality) tolerance and MI (mutual information) P-value threshold of 10 −8 . Protein activity inference for gene regulators 2 2 0
To infer the relative protein activity of the gene regulators at different epileptogenesis stages, we 2 2 1 applied the VIPER algorithm [24] to test for regulon (a group of genes that are regulated by the same 2 2 2 regulator) enrichment on stage-specific gene signatures. VIPER uses a probabilistic framework that 2 2 3
integrates target mode of regulation (i.e., activated, repressed or undetermined represented by an index 2 2 4 ranging from -1 to 1), statistical likelihoods of regulator-target interactions and target overlap between 2 2 5 different regulators (pleiotropy). To compute the enrichment of a protein's regulon in differentially 2 2 6
expressed genes, an analytic rank-based enrichment analysis (aREA) method, which conduct a statistical 2 2 7 analysis based on the mean of ranks, was used. The normalized enrichment score computed by aREA for 2 2 8 each regulon were employed to quantitatively represent the relators' relative protein activity in an 2 2 9
epileptogenesis stage compared to the control group. and mapped mouse Entrez ID identifiers to their human ortholog using the biomaRt [36] package. To investigate the molecular profiles underlying the epileptogenesis, we used the time-specific 2 5 5
hippocampal transcriptome data of rodent TLE models from five independent studies (Table 1) . These 2 5 6 studies contain both rat and mouse TLE models and the modeling approaches were various, including ranging from hours, to days and months. Based on the described tissue extraction time and phenotype, 2 6 0 the samples in each dataset were divided into the control group and groups of three epileptogenesis 2 6 1 stages, i.e., the acute phase, latent period and chronic epilepsy ( Fig. 1 and Table 1 ). After data 2 6 2 normalization and preprocessing, 99 expression profiles were obtained and the individual datasets were 2 6 3 then subjected to the PCA analysis. All datasets showed good separation among control samples and 2 6 4 samples of different epileptogenesis stages along the first two PCs, of which PC1 accounted for the 2 6 5 highest variation (27.8−49.8%) ( Fig. 2) .
6 6
To evaluate the differential gene expression between control samples and epileptic samples of each 2 6 7 epileptogenesis stage, we first applied the limma method [28] to individual datasets. The differentially 2 6 8
expressed genes (DEGs) were defined as those that achieved an absolute log 2 FC (fold change) > 0.5 2 6 9 and a FDR < 0.05 between control and epilepsy. There were four, three and two datasets that contain 2 7 0 samples of the acute, latent and chronic stages, respectively. For the acute and latent stages, the 2 7 1 differential expression analysis yielded gene lists with very small overlap across the datasets. While for 2 7 2 the chronic phase, no DEGs were detected in one of the two datasets ( Supplementary Fig. S1a ). We 2 7 3 then applied another differential expression analysis method RP [29] that differs from the linear 2 7 4
modeling-based approaches. RP is a rank-based technique that detects genes that consistently appear (pfp < 0.05). The RP-based method depicts a slightly better but still small overlap of DEGs among 2 7 8 datasets ( Supplementary Fig. S1b) . These results suggest that direct comparison across individual 2 7 9
datasets was not feasible due to the heterogeneity of experimental approaches and profiling platforms.
Since the RP algorithm transforms the actual expression values into ranks, it has the ability to handle 2 8 1 variability among datasets and can be adapt to integrate datasets from multiple origins [40] . We thus 2 8 2 adopted the RP for meta-analysis for each of the three epileptogenesis stages. We obtained a set of 2404, 9 / 1 7 based on a probabilistic framework that directly integrates target mode of regulation, regulator-target 3 4 1 interaction confidence and target overlap between different regulators.
4 2
Differential protein activities of 521 regulators were obtained for all three epileptogenesis stages. For 3 4 3 each stage, key regulators were defined as those with absolute differential protein activity score greater 3 4 4 than two, which represents a significant activity alteration compared to the control group (Fig. 4a) . There 3 4 5
were 214, 198 and 156 key regulators respectively associated with the acute, latent and chronic stage 3 4 6 ( Fig. 4b) . 43% of the key regulators were dysregulated in all three stages, indicating that these regulators 3 4 7
were immediately involved in the epileptogenesis following SE, and exhibited continuing changes regulators (Supplementary Fig. S4 ). Regulator activities in both M1 and M8 were upregulated during the 3 5 0
epileptogenesis, yet their activities exhibited opposite changing trends. Whereas M1 regulators were 3 5 1 mainly associated with acute response after the SE, M8 regulators may play major roles in the latent and 3 5 2 chronic epilepsy stages (Fig. 4c) . Regulators in M3, 6 and 7 show constant downregulated activity at all 3 5 3 three epileptogenesis stages.
3 5 4
To understand the molecular processes affected by these key regulators, we performed enrichment 3 5 5
analysis against the KEGG pathways database [38] . The analysis showed that the key regulators were 3 5 6
involved in signaling pathways related to chemical synaptic transmission, immune response, growth 3 5 7
factor signaling, and pathways related to cell proliferation and death (Fig. 4d) . Among the synaptic Besides, the Retrograde endocannabinoid signaling, which can suppress both excitatory and some 3 6 1 inhibitory synapses, was also enriched with the key regulators (adjusted P-value = 1.7E−04). investigation as potential anti-epileptogenic targets. the epileptogenic process, we proposed an analytic framework which comprises four steps. Firstly, the 6 4 5
hippocampal transcriptome datasets of rodent TLE models were collected and divided into the acute, 6 4 6 latent and chronic stages based on the described tissue extraction time and phenotypes. Meta-analysis 6 4 7
was then performed using the RankProd method to evaluate differential gene expression and to generate 6 4 8
the gene meta-signature for each stage. Secondly, to elucidate the functional organization of genes under 0 1 7 0 2 7 0 3 
